CELSIGNIA

Serial Number 88920922
606

Registration Progress

Application Filed
May 18, 2020
Under Examination
Apr 27, 2021
Approved for Publication
Mar 2, 2021
Published for Opposition
Mar 2, 2021
Registered

Trademark Image

CELSIGNIA

Basic Information

Serial Number
88920922
Filing Date
May 18, 2020
Published for Opposition
March 2, 2021
Abandonment Date
May 29, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 29, 2023
Classes
005

Rights Holder

Celcuity Inc.

03
Address
Suite 100
16305 36th Avenue North
Minneapolis, MN 55446

Ownership History

Celcuity Inc.

Original Applicant
03
Minneapolis, MN

Celcuity Inc.

Owner at Publication
03
Minneapolis, MN

Legal Representation

Attorney
Anthony Laurentano

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
May 30, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 29, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 27, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 27, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 28, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 26, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 26, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 27, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 27, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 10, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 25, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 13, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 13, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 13, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 13, 2021 ALIE A ASSIGNED TO LIE Loading...
Jan 13, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 14, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 14, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 14, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 21, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 21, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 21, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical diagnostic test that employs in vitro assays for analyzing cancer cells to identify specific biological drivers of the cancer; medical cell based assays for testing cancer cells for use in selecting therapeutics in the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005